Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure.
Saved in:
| Title: | Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure. |
|---|---|
| Authors: | Yang J; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China., He Y; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China., Pu J; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China., Zhang Y; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China., Zhou J; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China., Qiu L; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China. liruqiutj@163.com. |
| Source: | Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2026 May; Vol. 41 (5), pp. 1361-1370. Date of Electronic Publication: 2025 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41385077 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China.<br /><searchLink fieldCode="AU" term="%22Pu+J%22">Pu J</searchLink>; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China.<br /><searchLink fieldCode="AU" term="%22Qiu+L%22">Qiu L</searchLink>; Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Ave. No. 1095, Wuhan, 430030, China. liruqiutj@163.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228708728%22">Pediatric nephrology (Berlin, Germany)</searchLink> [Pediatr Nephrol] 2026 May; Vol. 41 (5), pp. 1361-1370. <i>Date of Electronic Publication: </i>2025 Dec 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8708728 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-198X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220931041X%22">0931041X </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Nephrol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41385077 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00467-025-07069-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1361 Titles: – TitleFull: Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang J – PersonEntity: Name: NameFull: He Y – PersonEntity: Name: NameFull: Pu J – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Zhou J – PersonEntity: Name: NameFull: Qiu L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-198X Numbering: – Type: volume Value: 41 – Type: issue Value: 5 Titles: – TitleFull: Pediatric nephrology (Berlin, Germany) Type: main |
| ResultId | 1 |
